// App-Quantinova.ai

4360 : Inhibition of HSP90 enhances T cell-mediated antitumor immune responses through expression of interferon-alpha response Genes

Researchers

Presenter

  • Rina M. Mbofung

Principal Investigators

  • Shruti Malu

  • Chengwen Liu

  • Leila Williams

  • Weiyi Peng

  • Zhe Wang

  • Satyendra Tripathi

  • Trang Tieu

  • Shuping Zhao

  • Seram Devi

  • Isere Kuiatse

  • Emily Ashkin

  • Leah Bailey

  • Jason Roszik

  • Samir Hanash

  • Timothy Heffernan

  • Richard E. Davis

  • Rodabe N. Amaria

  • Patrick Hwu

Medical Centers

  • 1.MD Anderson Cancer Center, Houston, TX

  • Dana-Farber Cancer Institute, Boston, MA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Melanoma

  • Solid malignancies

Biomarkers

  • Glycoprotein 100

  • tumor-infiltrating lymphocytes

Drug/Treatment

  • Interferon alpha

  • ganetespib

  • Ipilimumab

  • Interferon

  • Anti-CTLA4

  • GP100

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved